[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fyA6HE6DsyiyA7U0NMTdvYNM9Ae6V7HWQm0k8yNm9Ebo":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":39,"rows":46},"The University of The West Indies",[4],61,false,9,6,10825,1,41,[14,17,20,22,24,26,28,31],{"name":15,"count":16},"Sickle Cell Disease",5,{"name":18,"count":19},"Platelet Dysfunction Due to Drugs",4,{"name":21,"count":19},"Back Pain",{"name":23,"count":19},"Low Back Pain",{"name":25,"count":19},"Musculoskeletal Pain",{"name":27,"count":19},"Neck Pain",{"name":29,"count":30},"Platelet Dysfunction",3,{"name":32,"count":30},"Diabetes Mellitus",[34],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT05730244","A Study of the Clinical Efficacy and Safety of 20% Cassia Alata Extract Against Tinea Versicolor","2026-01-31","20% Cassia alata cream",[40,41,42,43,44,45],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[47,72,98,127,145,163,181,209,240,258,276,294,319,343,368,394,412,430,454,478,502,525,551,577,603,629,661,679,697,715,733,757,784],{"intervention":38,"totalTrials":11,"cells":48},{"EARLY_PHASE1":49,"PHASE1":52,"PHASE2":64,"PHASE3":66,"PHASE4":68,"NA":70},{"trials":50,"activeCount":51},[],0,{"trials":53,"activeCount":11,"soonestReadout":37},[54],{"nctId":35,"briefTitle":36,"status":55,"phases":56,"primaryCompletion":37,"completion":57,"start":58,"enrollment":59,"conditions":60,"interventions":63},"RECRUITING",[41],"2026-12-30","2025-03-01",20,[61,62],"Tinea Versicolor","Pityriasis Versicolor",[38],{"trials":65,"activeCount":51},[],{"trials":67,"activeCount":51},[],{"trials":69,"activeCount":51},[],{"trials":71,"activeCount":51},[],{"intervention":73,"totalTrials":11,"cells":74},"Dexamethasone",{"EARLY_PHASE1":75,"PHASE1":77,"PHASE2":79,"PHASE3":81,"PHASE4":83,"NA":96},{"trials":76,"activeCount":51},[],{"trials":78,"activeCount":51},[],{"trials":80,"activeCount":51},[],{"trials":82,"activeCount":51},[],{"trials":84,"activeCount":51},[85],{"nctId":86,"briefTitle":87,"status":88,"phases":89,"primaryCompletion":90,"completion":90,"start":91,"enrollment":92,"conditions":93,"interventions":95},"NCT04624360","The Effect of IV Dexamethasone on the Duration of Analgesia of Spinal Anaesthesia for C-Sections at a Jamaican Hospital","UNKNOWN",[44],"2020-12","2020-06-27",60,[94],"Pain, Postoperative",[73],{"trials":97,"activeCount":51},[],{"intervention":99,"totalTrials":11,"cells":100},"Losartan 50Mg Tab",{"EARLY_PHASE1":101,"PHASE1":103,"PHASE2":105,"PHASE3":107,"PHASE4":109,"NA":125},{"trials":102,"activeCount":51},[],{"trials":104,"activeCount":51},[],{"trials":106,"activeCount":51},[],{"trials":108,"activeCount":51},[],{"trials":110,"activeCount":51},[111],{"nctId":112,"briefTitle":113,"status":114,"phases":115,"primaryCompletion":116,"completion":117,"start":118,"enrollment":51,"conditions":119,"interventions":121},"NCT03978884","Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes","WITHDRAWN",[44],"2020-05-31","2020-12-31","2019-06-01",[32,120],"Hypertension",[99,122,123,124],"Losartan\u002FHydrochlorothiazide 50 Mg-12.5 Mg ORAL","Losartan\u002FHydrochlorothiazide 100 Mg-25 Mg ORAL","Amlodipine 5mg",{"trials":126,"activeCount":51},[],{"intervention":122,"totalTrials":11,"cells":128},{"EARLY_PHASE1":129,"PHASE1":131,"PHASE2":133,"PHASE3":135,"PHASE4":137,"NA":143},{"trials":130,"activeCount":51},[],{"trials":132,"activeCount":51},[],{"trials":134,"activeCount":51},[],{"trials":136,"activeCount":51},[],{"trials":138,"activeCount":51},[139],{"nctId":112,"briefTitle":113,"status":114,"phases":140,"primaryCompletion":116,"completion":117,"start":118,"enrollment":51,"conditions":141,"interventions":142},[44],[32,120],[99,122,123,124],{"trials":144,"activeCount":51},[],{"intervention":123,"totalTrials":11,"cells":146},{"EARLY_PHASE1":147,"PHASE1":149,"PHASE2":151,"PHASE3":153,"PHASE4":155,"NA":161},{"trials":148,"activeCount":51},[],{"trials":150,"activeCount":51},[],{"trials":152,"activeCount":51},[],{"trials":154,"activeCount":51},[],{"trials":156,"activeCount":51},[157],{"nctId":112,"briefTitle":113,"status":114,"phases":158,"primaryCompletion":116,"completion":117,"start":118,"enrollment":51,"conditions":159,"interventions":160},[44],[32,120],[99,122,123,124],{"trials":162,"activeCount":51},[],{"intervention":124,"totalTrials":11,"cells":164},{"EARLY_PHASE1":165,"PHASE1":167,"PHASE2":169,"PHASE3":171,"PHASE4":173,"NA":179},{"trials":166,"activeCount":51},[],{"trials":168,"activeCount":51},[],{"trials":170,"activeCount":51},[],{"trials":172,"activeCount":51},[],{"trials":174,"activeCount":51},[175],{"nctId":112,"briefTitle":113,"status":114,"phases":176,"primaryCompletion":116,"completion":117,"start":118,"enrollment":51,"conditions":177,"interventions":178},[44],[32,120],[99,122,123,124],{"trials":180,"activeCount":51},[],{"intervention":182,"totalTrials":11,"cells":183},"Exercise plus omega-3 supplement",{"EARLY_PHASE1":184,"PHASE1":186,"PHASE2":188,"PHASE3":190,"PHASE4":205,"NA":207},{"trials":185,"activeCount":51},[],{"trials":187,"activeCount":51},[],{"trials":189,"activeCount":51},[],{"trials":191,"activeCount":51},[192],{"nctId":193,"briefTitle":194,"status":88,"phases":195,"primaryCompletion":196,"completion":197,"start":198,"enrollment":199,"conditions":200,"interventions":204},"NCT04053218","Intervening to Repair Cognitive and Behavioural Problems in Adults Exposed to Childhood Malnutrition",[43],"2020-09-07","2020-12-14","2018-01-15",100,[201,202,203],"Severe Acute Malnutrition","Cognitive Impairment","Emotional Disturbances",[182],{"trials":206,"activeCount":51},[],{"trials":208,"activeCount":51},[],{"intervention":210,"totalTrials":11,"cells":211},"Midazolam",{"EARLY_PHASE1":212,"PHASE1":214,"PHASE2":216,"PHASE3":218,"PHASE4":236,"NA":238},{"trials":213,"activeCount":51},[],{"trials":215,"activeCount":51},[],{"trials":217,"activeCount":51},[],{"trials":219,"activeCount":51},[220],{"nctId":221,"briefTitle":222,"status":88,"phases":223,"primaryCompletion":224,"completion":225,"start":226,"enrollment":227,"conditions":228,"interventions":232},"NCT02444260","A Trial of Local Anaesthesia Versus Local Anaesthesia and Conscious Sedation for Hernioplasty",[43],"2015-12","2016-12","2013-12",180,[229,230,231],"Inguinal Hernia","Anesthesia, Local","Conscious Sedation",[210,233,234,235],"Intravenous Normal Saline","Bupivocaine","Lignocaine HCl",{"trials":237,"activeCount":51},[],{"trials":239,"activeCount":51},[],{"intervention":233,"totalTrials":11,"cells":241},{"EARLY_PHASE1":242,"PHASE1":244,"PHASE2":246,"PHASE3":248,"PHASE4":254,"NA":256},{"trials":243,"activeCount":51},[],{"trials":245,"activeCount":51},[],{"trials":247,"activeCount":51},[],{"trials":249,"activeCount":51},[250],{"nctId":221,"briefTitle":222,"status":88,"phases":251,"primaryCompletion":224,"completion":225,"start":226,"enrollment":227,"conditions":252,"interventions":253},[43],[229,230,231],[210,233,234,235],{"trials":255,"activeCount":51},[],{"trials":257,"activeCount":51},[],{"intervention":234,"totalTrials":11,"cells":259},{"EARLY_PHASE1":260,"PHASE1":262,"PHASE2":264,"PHASE3":266,"PHASE4":272,"NA":274},{"trials":261,"activeCount":51},[],{"trials":263,"activeCount":51},[],{"trials":265,"activeCount":51},[],{"trials":267,"activeCount":51},[268],{"nctId":221,"briefTitle":222,"status":88,"phases":269,"primaryCompletion":224,"completion":225,"start":226,"enrollment":227,"conditions":270,"interventions":271},[43],[229,230,231],[210,233,234,235],{"trials":273,"activeCount":51},[],{"trials":275,"activeCount":51},[],{"intervention":235,"totalTrials":11,"cells":277},{"EARLY_PHASE1":278,"PHASE1":280,"PHASE2":282,"PHASE3":284,"PHASE4":290,"NA":292},{"trials":279,"activeCount":51},[],{"trials":281,"activeCount":51},[],{"trials":283,"activeCount":51},[],{"trials":285,"activeCount":51},[286],{"nctId":221,"briefTitle":222,"status":88,"phases":287,"primaryCompletion":224,"completion":225,"start":226,"enrollment":227,"conditions":288,"interventions":289},[43],[229,230,231],[210,233,234,235],{"trials":291,"activeCount":51},[],{"trials":293,"activeCount":51},[],{"intervention":295,"totalTrials":11,"cells":296},"SGLT2 inhibitor",{"EARLY_PHASE1":297,"PHASE1":299,"PHASE2":301,"PHASE3":303,"PHASE4":315,"NA":317},{"trials":298,"activeCount":51},[],{"trials":300,"activeCount":51},[],{"trials":302,"activeCount":51},[],{"trials":304,"activeCount":51},[305],{"nctId":306,"briefTitle":307,"status":308,"phases":309,"primaryCompletion":310,"completion":310,"start":311,"enrollment":312,"conditions":313,"interventions":314},"NCT04342819","The Effect of empagliFlozin on Platelet Function profilEs in diabetiC patienTs - The EFFECT Study.","COMPLETED",[42,43],"2021-12-31","2020-01-01",25,[18],[295],{"trials":316,"activeCount":51},[],{"trials":318,"activeCount":51},[],{"intervention":320,"totalTrials":11,"cells":321},"DAPA Tx",{"EARLY_PHASE1":322,"PHASE1":324,"PHASE2":326,"PHASE3":328,"PHASE4":339,"NA":341},{"trials":323,"activeCount":51},[],{"trials":325,"activeCount":51},[],{"trials":327,"activeCount":51},[],{"trials":329,"activeCount":51},[330],{"nctId":331,"briefTitle":332,"status":308,"phases":333,"primaryCompletion":334,"completion":334,"start":335,"enrollment":336,"conditions":337,"interventions":338},"NCT04400760","The Effect of Dapagliflozin on Platelet Function testinG Profiles in Diabetic PatiEnts.",[42,43],"2022-06-30","2020-05-01",40,[29],[320],{"trials":340,"activeCount":51},[],{"trials":342,"activeCount":51},[],{"intervention":344,"totalTrials":11,"cells":345},"200 micrograms of misoprostol",{"EARLY_PHASE1":346,"PHASE1":348,"PHASE2":350,"PHASE3":352,"PHASE4":364,"NA":366},{"trials":347,"activeCount":51},[],{"trials":349,"activeCount":51},[],{"trials":351,"activeCount":51},[],{"trials":353,"activeCount":51},[354],{"nctId":355,"briefTitle":356,"status":88,"phases":357,"primaryCompletion":358,"completion":358,"start":359,"enrollment":360,"conditions":361,"interventions":363},"NCT04044287","Misoprostol in the Prevention of Postpartum Haemorrhage",[43],"2019-12-31","2013-01-01",1496,[362],"Postpartum Hemorrhage",[344],{"trials":365,"activeCount":51},[],{"trials":367,"activeCount":51},[],{"intervention":369,"totalTrials":11,"cells":370},"Remdesivir",{"EARLY_PHASE1":371,"PHASE1":373,"PHASE2":375,"PHASE3":377,"PHASE4":390,"NA":392},{"trials":372,"activeCount":51},[],{"trials":374,"activeCount":51},[],{"trials":376,"activeCount":51},[],{"trials":378,"activeCount":51},[379],{"nctId":380,"briefTitle":381,"status":88,"phases":382,"primaryCompletion":383,"completion":310,"start":384,"enrollment":199,"conditions":385,"interventions":387},"NCT04647669","World Health Organization (WHO) COVID-19 Solidarity Trial for COVID-19 Treatments",[43],"2021-11-30","2021-06-01",[386],"Covid19",[369,388,389],"Acalabrutinib","Interferon beta-1a",{"trials":391,"activeCount":51},[],{"trials":393,"activeCount":51},[],{"intervention":388,"totalTrials":11,"cells":395},{"EARLY_PHASE1":396,"PHASE1":398,"PHASE2":400,"PHASE3":402,"PHASE4":408,"NA":410},{"trials":397,"activeCount":51},[],{"trials":399,"activeCount":51},[],{"trials":401,"activeCount":51},[],{"trials":403,"activeCount":51},[404],{"nctId":380,"briefTitle":381,"status":88,"phases":405,"primaryCompletion":383,"completion":310,"start":384,"enrollment":199,"conditions":406,"interventions":407},[43],[386],[369,388,389],{"trials":409,"activeCount":51},[],{"trials":411,"activeCount":51},[],{"intervention":389,"totalTrials":11,"cells":413},{"EARLY_PHASE1":414,"PHASE1":416,"PHASE2":418,"PHASE3":420,"PHASE4":426,"NA":428},{"trials":415,"activeCount":51},[],{"trials":417,"activeCount":51},[],{"trials":419,"activeCount":51},[],{"trials":421,"activeCount":51},[422],{"nctId":380,"briefTitle":381,"status":88,"phases":423,"primaryCompletion":383,"completion":310,"start":384,"enrollment":199,"conditions":424,"interventions":425},[43],[386],[369,388,389],{"trials":427,"activeCount":51},[],{"trials":429,"activeCount":51},[],{"intervention":431,"totalTrials":11,"cells":432},"Trimetazidine",{"EARLY_PHASE1":433,"PHASE1":435,"PHASE2":437,"PHASE3":448,"PHASE4":450,"NA":452},{"trials":434,"activeCount":51},[],{"trials":436,"activeCount":51},[],{"trials":438,"activeCount":51},[439],{"nctId":440,"briefTitle":441,"status":308,"phases":442,"primaryCompletion":443,"completion":443,"start":444,"enrollment":445,"conditions":446,"interventions":447},"NCT03603249","Trimetazidine as an Adjunct to Enhance Clopidogrel Response.",[42],"2019-04-01","2018-07-01",24,[18],[431],{"trials":449,"activeCount":51},[],{"trials":451,"activeCount":51},[],{"trials":453,"activeCount":51},[],{"intervention":455,"totalTrials":11,"cells":456},"Convalescent Plasma",{"EARLY_PHASE1":457,"PHASE1":459,"PHASE2":461,"PHASE3":472,"PHASE4":474,"NA":476},{"trials":458,"activeCount":51},[],{"trials":460,"activeCount":51},[],{"trials":462,"activeCount":51},[463],{"nctId":464,"briefTitle":465,"status":88,"phases":466,"primaryCompletion":467,"completion":467,"start":384,"enrollment":468,"conditions":469,"interventions":471},"NCT04644198","Convalescent Plasma Transfusion in Severe COVID-19 Patients in Jamaica",[42],"2021-12-01",30,[470],"COVID-19, Convalescent Plasma Treatment",[455],{"trials":473,"activeCount":51},[],{"trials":475,"activeCount":51},[],{"trials":477,"activeCount":51},[],{"intervention":479,"totalTrials":11,"cells":480},"Aspirin 81Mg Ec Tab",{"EARLY_PHASE1":481,"PHASE1":483,"PHASE2":485,"PHASE3":496,"PHASE4":498,"NA":500},{"trials":482,"activeCount":51},[],{"trials":484,"activeCount":51},[],{"trials":486,"activeCount":51},[487],{"nctId":488,"briefTitle":489,"status":308,"phases":490,"primaryCompletion":491,"completion":491,"start":492,"enrollment":493,"conditions":494,"interventions":495},"NCT06228820","Aspirin Resistance in Trinidad.",[42],"2024-12-15","2024-01-15",48,[18],[479],{"trials":497,"activeCount":51},[],{"trials":499,"activeCount":51},[],{"trials":501,"activeCount":51},[],{"intervention":503,"totalTrials":11,"cells":504},"Ticagrelor",{"EARLY_PHASE1":505,"PHASE1":507,"PHASE2":509,"PHASE3":519,"PHASE4":521,"NA":523},{"trials":506,"activeCount":51},[],{"trials":508,"activeCount":51},[],{"trials":510,"activeCount":51},[511],{"nctId":512,"briefTitle":513,"status":308,"phases":514,"primaryCompletion":515,"completion":515,"start":516,"enrollment":312,"conditions":517,"interventions":518},"NCT04206176","The Effects of loW Dose tIcagrelor on Platelet Function Testing in Patients With Stable Coronary arTery Disease",[41,42],"2020-03-31","2019-10-01",[18],[503],{"trials":520,"activeCount":51},[],{"trials":522,"activeCount":51},[],{"trials":524,"activeCount":51},[],{"intervention":526,"totalTrials":11,"cells":527},"P1",{"EARLY_PHASE1":528,"PHASE1":530,"PHASE2":543,"PHASE3":545,"PHASE4":547,"NA":549},{"trials":529,"activeCount":51},[],{"trials":531,"activeCount":51},[532],{"nctId":533,"briefTitle":534,"status":88,"phases":535,"primaryCompletion":536,"completion":537,"start":538,"enrollment":539,"conditions":540,"interventions":542},"NCT03744091","Evaluation of the Pharmacokinetics of Prana P1 Capsules",[41],"2019-01-23","2019-08-23","2018-07-16",13,[541],"Healthy",[526],{"trials":544,"activeCount":51},[],{"trials":546,"activeCount":51},[],{"trials":548,"activeCount":51},[],{"trials":550,"activeCount":51},[],{"intervention":552,"totalTrials":11,"cells":553},"Colchicine 0.5 MG oral tablet twice daily",{"EARLY_PHASE1":554,"PHASE1":556,"PHASE2":569,"PHASE3":571,"PHASE4":573,"NA":575},{"trials":555,"activeCount":51},[],{"trials":557,"activeCount":51},[558],{"nctId":559,"briefTitle":560,"status":308,"phases":561,"primaryCompletion":562,"completion":563,"start":564,"enrollment":565,"conditions":566,"interventions":568},"NCT06567678","The Effect of Colchicine on Platelet Function Profiles in Patients With Stable Coronary Artery Disease",[41],"2024-10-20","2024-11-04","2024-08-21",22,[567],"Coronary Artery Disease",[552],{"trials":570,"activeCount":51},[],{"trials":572,"activeCount":51},[],{"trials":574,"activeCount":51},[],{"trials":576,"activeCount":51},[],{"intervention":578,"totalTrials":11,"cells":579},"Triamcinolone",{"EARLY_PHASE1":580,"PHASE1":593,"PHASE2":595,"PHASE3":597,"PHASE4":599,"NA":601},{"trials":581,"activeCount":51},[582],{"nctId":583,"briefTitle":584,"status":88,"phases":585,"primaryCompletion":586,"completion":587,"start":588,"enrollment":589,"conditions":590,"interventions":592},"NCT06032039","Corticosteroid vs Platelet-Rich Plasma Intra-articular Injections in the Treatment of Knee Osteoarthritis.",[40],"2024-10-31","2025-04-30","2023-10-01",160,[591],"Knee Osteoarthritis",[578],{"trials":594,"activeCount":51},[],{"trials":596,"activeCount":51},[],{"trials":598,"activeCount":51},[],{"trials":600,"activeCount":51},[],{"trials":602,"activeCount":51},[],{"intervention":604,"totalTrials":11,"cells":605},"Cannabidiol Oil",{"EARLY_PHASE1":606,"PHASE1":619,"PHASE2":621,"PHASE3":623,"PHASE4":625,"NA":627},{"trials":607,"activeCount":51},[608],{"nctId":609,"briefTitle":610,"status":88,"phases":611,"primaryCompletion":612,"completion":613,"start":614,"enrollment":615,"conditions":616,"interventions":618},"NCT06137027","Cannabidiol Oil Extract for Prevention of Postoperative Nausea and Vomiting",[40],"2024-01-31","2024-02-29","2023-09-21",120,[617],"Postoperative Nausea and Vomiting",[604],{"trials":620,"activeCount":51},[],{"trials":622,"activeCount":51},[],{"trials":624,"activeCount":51},[],{"trials":626,"activeCount":51},[],{"trials":628,"activeCount":51},[],{"intervention":630,"totalTrials":11,"cells":631},"Dibenzyl trisulphide",{"EARLY_PHASE1":632,"PHASE1":651,"PHASE2":653,"PHASE3":655,"PHASE4":657,"NA":659},{"trials":633,"activeCount":51},[634],{"nctId":635,"briefTitle":636,"status":88,"phases":637,"primaryCompletion":638,"completion":638,"start":639,"enrollment":640,"conditions":641,"interventions":646},"NCT04113096","Dibenzyl Trisulphide (GUINEAHEN WEED) for Stage IV Cancer",[40],"2020-09-30","2018-10-01",104,[642,643,644,645],"Stage IV Prostate Cancer","Stage IV Colon Cancer","Stage IV Breast Cancer","Stage IV Cancer of the Cervix",[630,630,630,630,647,648,649,650],"Stage IV Breast Cancer Placebo","Stage IV: Colon Cancer Placebo","Cervical Cancer Stage IV Placebo","Cancer of the Prostate Placebo",{"trials":652,"activeCount":51},[],{"trials":654,"activeCount":51},[],{"trials":656,"activeCount":51},[],{"trials":658,"activeCount":51},[],{"trials":660,"activeCount":51},[],{"intervention":647,"totalTrials":11,"cells":662},{"EARLY_PHASE1":663,"PHASE1":669,"PHASE2":671,"PHASE3":673,"PHASE4":675,"NA":677},{"trials":664,"activeCount":51},[665],{"nctId":635,"briefTitle":636,"status":88,"phases":666,"primaryCompletion":638,"completion":638,"start":639,"enrollment":640,"conditions":667,"interventions":668},[40],[642,643,644,645],[630,630,630,630,647,648,649,650],{"trials":670,"activeCount":51},[],{"trials":672,"activeCount":51},[],{"trials":674,"activeCount":51},[],{"trials":676,"activeCount":51},[],{"trials":678,"activeCount":51},[],{"intervention":648,"totalTrials":11,"cells":680},{"EARLY_PHASE1":681,"PHASE1":687,"PHASE2":689,"PHASE3":691,"PHASE4":693,"NA":695},{"trials":682,"activeCount":51},[683],{"nctId":635,"briefTitle":636,"status":88,"phases":684,"primaryCompletion":638,"completion":638,"start":639,"enrollment":640,"conditions":685,"interventions":686},[40],[642,643,644,645],[630,630,630,630,647,648,649,650],{"trials":688,"activeCount":51},[],{"trials":690,"activeCount":51},[],{"trials":692,"activeCount":51},[],{"trials":694,"activeCount":51},[],{"trials":696,"activeCount":51},[],{"intervention":649,"totalTrials":11,"cells":698},{"EARLY_PHASE1":699,"PHASE1":705,"PHASE2":707,"PHASE3":709,"PHASE4":711,"NA":713},{"trials":700,"activeCount":51},[701],{"nctId":635,"briefTitle":636,"status":88,"phases":702,"primaryCompletion":638,"completion":638,"start":639,"enrollment":640,"conditions":703,"interventions":704},[40],[642,643,644,645],[630,630,630,630,647,648,649,650],{"trials":706,"activeCount":51},[],{"trials":708,"activeCount":51},[],{"trials":710,"activeCount":51},[],{"trials":712,"activeCount":51},[],{"trials":714,"activeCount":51},[],{"intervention":650,"totalTrials":11,"cells":716},{"EARLY_PHASE1":717,"PHASE1":723,"PHASE2":725,"PHASE3":727,"PHASE4":729,"NA":731},{"trials":718,"activeCount":51},[719],{"nctId":635,"briefTitle":636,"status":88,"phases":720,"primaryCompletion":638,"completion":638,"start":639,"enrollment":640,"conditions":721,"interventions":722},[40],[642,643,644,645],[630,630,630,630,647,648,649,650],{"trials":724,"activeCount":51},[],{"trials":726,"activeCount":51},[],{"trials":728,"activeCount":51},[],{"trials":730,"activeCount":51},[],{"trials":732,"activeCount":51},[],{"intervention":734,"totalTrials":11,"cells":735},"Clopidogrel",{"EARLY_PHASE1":736,"PHASE1":738,"PHASE2":740,"PHASE3":742,"PHASE4":744,"NA":746},{"trials":737,"activeCount":51},[],{"trials":739,"activeCount":51},[],{"trials":741,"activeCount":51},[],{"trials":743,"activeCount":51},[],{"trials":745,"activeCount":51},[],{"trials":747,"activeCount":51},[748],{"nctId":749,"briefTitle":750,"status":308,"phases":751,"primaryCompletion":752,"completion":753,"start":754,"enrollment":336,"conditions":755,"interventions":756},"NCT03667066","clOpidogrel \"resIstaNce\" in a Selected Population of Patients at a Tertiary Cardiovascular Center in Trinidad",[],"2018-01-01","2018-06-01","2017-09-01",[29],[734],{"intervention":758,"totalTrials":11,"cells":759},"Enalapril",{"EARLY_PHASE1":760,"PHASE1":762,"PHASE2":764,"PHASE3":766,"PHASE4":768,"NA":770},{"trials":761,"activeCount":51},[],{"trials":763,"activeCount":51},[],{"trials":765,"activeCount":51},[],{"trials":767,"activeCount":51},[],{"trials":769,"activeCount":51},[],{"trials":771,"activeCount":51},[772],{"nctId":773,"briefTitle":774,"status":88,"phases":775,"primaryCompletion":776,"completion":777,"start":778,"enrollment":468,"conditions":779,"interventions":782},"NCT01891292","Efficacy of Antioxidant Therapy Compared With Enalapril in Sickle Nephropathy",[45],"2014-08","2015-09","2013-07",[780,781],"Microalbuminuria","Sickle Cell Nephropathy",[758,783],"N-Acetylcysteine",{"intervention":783,"totalTrials":11,"cells":785},{"EARLY_PHASE1":786,"PHASE1":788,"PHASE2":790,"PHASE3":792,"PHASE4":794,"NA":796},{"trials":787,"activeCount":51},[],{"trials":789,"activeCount":51},[],{"trials":791,"activeCount":51},[],{"trials":793,"activeCount":51},[],{"trials":795,"activeCount":51},[],{"trials":797,"activeCount":51},[798],{"nctId":773,"briefTitle":774,"status":88,"phases":799,"primaryCompletion":776,"completion":777,"start":778,"enrollment":468,"conditions":800,"interventions":801},[45],[780,781],[758,783]]